AI-enabled Precision Medicine

Building engineered bacteriophage therapies

for infectious diseases and immunology

Designing Precision Medicines


We are trailblazers in the development of engineered bacteriophage products. Applying modern technologies, we are revolutionizing the treatment of bacterial infections and addressing unmet medical needs across immunology, oncology, and CNS disorders.

At our core is LOCUS, a technology stack that defines our precision products. From state-of-the-art robotics and automated biobanking to Al-driven cocktail prediction tools and cutting-edge synthetic biology techniques, we’re engineering phage cocktails with payloads that make them far more effective than their natural phage counterparts.

Learn more about how our clinical success sets us apart and how our world-class viral vector manufacturing facility produces cGMP clinical trial material at unprecedented potency and purity.

Combining data, computing, and robotics to design precision medicines

ELIMINATE

LBP-EC01 is a clinical-stage precision investigational therapeutic designed to target E. coli infections.


Our Partners

We are supported by an exceptional team of partners across academia,
government, large pharma, and investors.

Johnson & Johnson Innovation | JJDC
Artis Ventures
Viking
Barda
NC State University
North Carolina Biotechnology Center
CARB-X